Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of... (GlobeNewswire EN) +++ ALIGOS Aktie +4,51%

GlobeNewswire EN Nachrichten

GlobeNewswire verbreitet Pressemeldungen und Pflichtmitteilungen von börsennotierten Gesellschaften. Der Großteil der Mitteilungen stammt von Unternehmen aus Nordamerika, Großbritannien und den nordeuropäischen Ländern.
 
15.04.26 - 06:06
Notice Calling the Annual General Meeting of Shareholders (GlobeNewswire EN)
 
Dear shareholder of AS Tallink Grupp,...
15.04.26 - 05:30
Constellation Software′s Vela Operating Group Enters into Agreement to acquire a majority interest in Derbysoft Holdings Limited (GlobeNewswire EN)
 
TORONTO, April 14, 2026 (GLOBE NEWSWIRE) -- Constellation Software Inc. (“Constellation”) (TSX:CSU) today announced that Juniper Group, an operating group of Vela Software, has entered into a definitive agreement to acquire a majority interest in Derbysoft Holdings Limited (“Derbysoft”), the ultimate parent company of DerbySoft Inc....
15.04.26 - 04:42
Spyre Therapeutics Announces Pricing of Upsized $403.0 Million Public Offering of Common Stock (GlobeNewswire EN)
 
WALTHAM, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflammatory Bowel Disease (“IBD”) and other immune-mediated diseases, today announced the pricing of its previously announced underwritten public offering of 6,500,000 shares of its common stock at a price to the public of $62.00 per share. The gross proceeds to the Company from this offering are expected to be approximately $403.0 million, before deducting underwriting discounts and commissions and other offering expenses. In addition, the Company has granted the underwriters of the offering an option for a period of 30 days to purchase up to an additional approximately $60.5 million of shares of the Company's common stock at the public offering price, less the underwriting discount....
15.04.26 - 04:06
MindBio Appoints Market Maker Venture Liquidity Providers (GlobeNewswire EN)
 
MindBio has appointed Venture Liquidity Providers Inc to initiate its market making service to provide assistance in maintaining an orderly trading market...
15.04.26 - 03:54
Allogene Therapeutics Announces Pricing of Public Offering of Common Stock (GlobeNewswire EN)
 
SOUTH SAN FRANCISCO, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO) today announced the pricing of an underwritten public offering of 87,500,000 shares of its common stock at a price to the public of $2.00 per share. The gross proceeds from this offering are expected to be $175 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Allogene. The offering is expected to close on or about April 16, 2026, subject to customary closing conditions. In addition, Allogene has granted the underwriters for the offering a 30-day option to purchase up to 13,125,000 additional shares of its common stock at the public offering price, less the underwriting discounts and commissions....
15.04.26 - 03:42
T1 Energy Announces Pricing of Upsized Public Offering of Convertible Senior Notes Due 2031 (GlobeNewswire EN)
 
AUSTIN, Texas and NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) ( “T1,” “T1 Energy,” or the “Company”) today announced the pricing of its previously announced underwritten public offering of $160.0 million aggregate principal amount of its 4.00% convertible senior notes due 2031 (the “Convertible Notes” and such offering, the “Offering”). The Offering was upsized from the previously announced $125.0 million aggregate principal amount of Convertible Notes....
15.04.26 - 03:21
TeraWulf Announces Pricing of Upsized Common Stock Offering (GlobeNewswire EN)
 
EASTON, Md., April 14, 2026 (GLOBE NEWSWIRE) -- TeraWulf Inc. (NASDAQ: WULF) (the “Company” or “TeraWulf”) today announced the pricing of its previously announced public common stock offering (the “Offering”). The Company priced 47,400,000 shares at $19.00 per share, for gross proceeds of approximately $900 million, upsized from $800 million. The Offering is expected to close on April 16, 2026, subject to customary closing conditions....
15.04.26 - 03:18
Interfor to Announce First Quarter Results on May 14, 2026 (GlobeNewswire EN)
 
Analyst Conference Call – 8:00 a.m. Pacific, Friday, May 15, 2026 Analyst Conference Call – 8:00 a.m. Pacific, Friday, May 15, 2026...
15.04.26 - 02:57
ReconAfrica Provides Operational Update and Reports 2025 Year-End Results (GlobeNewswire EN)
 
CALGARY, Alberta, April 14, 2026 (GLOBE NEWSWIRE) -- Reconnaissance Energy Africa Ltd. (the “Company”, “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) is pleased to provide an operational update and report 2025 financial and operational results. The Company also renewed its shelf prospectus. All filings are available at SEDAR+ (sedarplus.ca)....
15.04.26 - 02:30
Prime Drink Group Announces Convertible Debenture, Board Appointment and Grant of Differed Share Units (GlobeNewswire EN)
 
MONTRÉAL, April 14, 2026 (GLOBE NEWSWIRE) -- Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces a non-brokered private placement (the “Private Placement”) of a minimum of 10 units (each, a “Unit”) and a maximum of 16 Units at a price of $250,000 per Unit, for minimum and maximum gross proceeds of $2,500,000 and $4,000,000, respectively....
15.04.26 - 02:12
Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products (GlobeNewswire EN)
 
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired an exclusive worldwide license to a patented chimeric antigen receptor (CAR) technology platform for precision-enhanced augmentation of therapeutic mesenchymal lineage stromal cell (MSC) products. Mesoblast plans to incorporate the engineered CARs to further boost effectiveness of Mesoblast's products, with the goal of enhancing the target specificity and augmenting inherent properties of immunomodulation and tissue regeneration....
15.04.26 - 02:03
O2Gold Terminates Quebec Aur Transaction (GlobeNewswire EN)
 
TORONTO, April 14, 2026 (GLOBE NEWSWIRE) -- O2Gold Inc. (NEX:OTGO.H) (“O2Gold” or the “Company”) announces today that it has elected to not extend the term of the share exchange agreement entered into with Quebec Aur Ltd. (“Quebec Aur”) and Quebec Aur's shareholders dated effective April 15, 2024, as amended, (the “Agreement”) pursuant to which the Company anticipated acquiring a gold mining exploration property in Quebec (the “Acquisition”). As a result the Agreement has been terminated and the Acquisition will not be completed. The Company has also cancelled its previously announced non-brokered private placement financing of 18 million units and 16 million flow-through common shares (the “Offering”) and its previously announced shares for debt settlement agreement, pursuant to which the Company intended to issue 7,000,000 of its common shares to settle all amounts owing by the Quebec Aur to Q-Gold Resources Ltd (the “Settlement”)....
15.04.26 - 01:48
GoldHaven Announces Change of Auditor (GlobeNewswire EN)
 
VANCOUVER, British Columbia, April 14, 2026 (GLOBE NEWSWIRE) -- GoldHaven Resources Corp. (“GoldHaven” or the “Company”) (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) announces that pursuant to National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102”), on April 10, 2026, Smythe LLP, Chartered Professional Accountants (“Smythe”), was asked to resign by the directors of the Company (the “Board”), as the Company's auditor, and the Board resolved to appoint Davidson & Company LLP, Chartered Professional Accountants (“Davidson”), as the Company's successor auditor (the “Change of Auditor”). GoldHaven's request of Smythe to resign did not occur because of any reportable disagreement or unresolved issue involving the Company, or any consultation with Davidson and was considered, approved and recommended by the Audit Committee of the Board, as was the decision to appoint Davidson as successor auditor. In the opinion of the Company, there have been no modified opinions...
15.04.26 - 01:45
Northrop Grumman′s B-21 Raider Powers Unmatched Long-Range Strike Capability (GlobeNewswire EN)
 
Aerial refueling in test unlocks additional speed, flexibility in future operations Aerial refueling in test unlocks additional speed, flexibility in future operations...
15.04.26 - 01:36
POET Technologies Provides Clarity on its Passive Foreign Investment Company (PFIC) Status (GlobeNewswire EN)
 
Commits to Taking Actions to Address Potential Tax Consequences to U.S. Shareholders...
15.04.26 - 01:21
Imperial Reports Mount Polley Production Update for 2026 First Quarter (GlobeNewswire EN)
 
VANCOUVER, British Columbia, April 14, 2026 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (“Imperial”) (TSX:III) reports production from Mount Polley mine for the 2026 first quarter of 4.399 million pounds copper and 7,608 ounces gold. Copper production was down 51% and gold production was down 28%, on lower grades, recoveries and throughput compared to the first quarter of 2025....
15.04.26 - 01:06
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma (GlobeNewswire EN)
 
MELBOURNE, Australia and INDIANAPOLIS, April 15, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient has been dosed with TLX101-Tx (¹³¹I-iodofalan) in Telix's pivotal IPAX BrIGHT trial1, marking the first radiopharmaceutical therapy to enter Phase 3 development for glioblastoma, an aggressive form of brain cancer....
15.04.26 - 01:03
QuasarEdge Acquisition Corp Prices $100 Million Initial Public Offering (GlobeNewswire EN)
 
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- QuasarEdge Acquisition Corp, a blank check company incorporated in the Cayman Islands as an exempted company (the “Company”), today announced the pricing of its initial public offering (the “IPO”) of 10,000,000 units at an offering price of $10.00 per unit. The units are expected to commence trading on April 15, 2026 on the New York Stock Exchange (“NYSE”) under the ticker symbol “QREDU.” Each unit sold in the offering consists of one ordinary share and one right to receive one-fourth (1/4) of one ordinary share upon the consummation of an initial business combination. Only whole rights will be exchangeable for ordinary shares.  Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be listed on NYSE under the symbols “QRED” and “QREDR,” respectively....
15.04.26 - 01:03
Sompo Expands Capabilities in Australia with New Team and Enhanced Strategic Focus (GlobeNewswire EN)
 
SYDNEY, Australia, April 14, 2026 (GLOBE NEWSWIRE) -- Sompo, a leading global provider of commercial and consumer property and casualty (re)insurance, today announced the expansion of its operations in Australia as it strengthens its presence and long-term commitment to the market. As part of this strategic growth, Sompo has recruited a highly experienced team of local underwriters who bring established expertise across Property, Casualty, Financial Lines, Energy and Construction. The specialist team of nine, which is known for its solutions-based, client-centric approach, will be based in offices located in Sydney and Melbourne*. Their extensive market knowledge will enhance Sompo's capabilities, support strong governance and position the business to deliver solutions to clients and brokers throughout the region. It also further aligns with Sompo's goal to become one of Australia's leading insurance providers....
15.04.26 - 00:33
Five Star Bancorp Announces First Quarter 2026 Earnings Release Date and Webcast (GlobeNewswire EN)
 
RANCHO CORDOVA, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”), a holding company that operates through its wholly owned banking subsidiary, Five Star Bank (the “Bank”), expects to report its financial results for the quarter ended March 31, 2026, after the stock market closes on Monday, April 27, 2026....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wir sind ebensowenig Herren unserer Träume, wie unserer Gedanken. - Voltaire
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!